AGL

Sell Steven

Known title: CEO & PresidentCIK: 0001479123

Sell Steven's purchase track record

How the stock did after each of Sell Steven's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
3
of 3 since November 18, 2022
Stock higher 6 months later
67%
3 months: 33%
Median 6-month return
+20.8%
3 months: -32.9%
Beat the S&P 500
67%
median +21.5% vs. index
PurchaseStockAmount3 months6 months
9/12/2024AGL$67K-32.9%+20.8%
11/21/2023AGL$498K-38.3%-49.5%
11/18/2022AGL$50K+32.7%+27.3%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

Agilon Health Stock Moves Amid Peer Comparison. Recent market activity for Agilon Health has drawn attention to how its performance compares with other medical sector stocks this year. The company's stock is currently trading near a significant support level, which may be influencing investor sentiment. Analysts maintain a wide range of price targets, reflecting varying views on the company's future trajectory.

this person other insiders at AGL

Transaction History

AGL▼ Sell$125K
AGL▼ Sell$44K
AGL▲ Buy$0
AGL▲ Buy—
AGL▼ Sell$63K
AGL▲ Buy$67K
AGL▲ Buy$0
AGL▼ Sell$39K
AGL▲ Buy$498K
AGL▲ Buy$0
AGL▼ Sell$120K
AGL▲ Buy$50K
AGL▲ Buy$0
AGL▲ Buy$450K
AGL▼ Sell$2.9M

We use analytics to understand how market-wall is used. No personal data is sold.